Loading clinical trials...
Loading clinical trials...
[C-11]NPA PET-amphetamine in Cocaine Use Disorders (Aim 2)
Conditions
Interventions
Baseline [C-11]NPA PET Scan
d-amphetamine
+1 more
Locations
1
United States
University of PIttsburgh
Pittsburgh, Pennsylvania, United States
Start Date
January 31, 2021
Primary Completion Date
September 1, 2028
Completion Date
September 1, 2028
Last Updated
June 5, 2025
NCT07071779
NCT04721418
NCT06125054
NCT06701487
NCT07532460
NCT05529927
Lead Sponsor
Rajesh Narendran
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions